Edwards Lifesciences Corp (EW) 115.85 $EW Masim
Post# of 273256
Posted On: 09/06/2016 9:13:04 AM
Edwards Lifesciences Corp (EW) 115.85 $EW
Masimo (MASI) Hits 52-Week High: What's Backing the Stock?
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 8:07AM CDT
Shares of Masimo Corp. (MASI) scaled a new 52-week high of $59.90 on Sep 2.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EW: 115.85 (-0.02), NUVA: 66.74 (+0.68)
Edwards Lifesciences To Present At The 11th Annual Wells Fargo Healthcare Conference
PR Newswire - Thu Sep 01, 9:10AM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the 11th Annual Wells Fargo Healthcare Conference at the Westin Boston Waterfront in Boston, Massachusetts on Thursday, September 8, 2016.
EW: 115.85 (-0.02), WFC: 50.75 (+0.20)
Medical Equipment Stocks Technical Reports -- St. Jude Medical, Wright Medical, Edwards Lifesciences, and Steris
PR Newswire - Tue Aug 23, 7:05AM CDT
This morning's stocks in focus on Stock-Callers.com belong in the Healthcare sector which rose 0.3% in midday trading on Monday, August 22, 2016. As per Forbes, the Health Care Select Sector SPDR ETF (XLV) climbed 0.2%, up 4.21% on an YTD basis. Let us now review the following Medical Appliances and Equipment equities and see how they fared at the close: St. Jude Medical Inc. (NYSE: STJ), Wright Medical Group N.V. (NASDAQ: WMGI), Edwards Lifesciences Corp. (NYSE: EW), and Steris PLC (NYSE: STE). Download the free research reports on these stocks today:
WMGI: 24.71 (+0.10), STE: 71.00 (+0.89), EW: 115.85 (-0.02), STJ: 78.65 (+0.51), WMGIZ: 1.35 (unch)
Edwards Lifesciences: Rallies on Strong THV Sales, View Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 5:05PM CDT
Geographically Edwards Lifesciences (EW) excelled in both the U.S. as well as overseas, particularly in its transcatheter heart valve (THV) product segment.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EW: 115.85 (-0.02), IDXX: 114.09 (+0.93)
Stock Market News for August 19, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:10AM CDT
Benchmarks ended slightly higher on Thursday, boosted by gains in energy shares
EW: 115.85 (-0.02), DE: 84.47 (+0.42), WMT: 72.56 (+0.06), XOM: 87.60 (+0.18), TMUS: 47.29 (+1.04), GPS: 23.92 (-0.63), CVX: 101.10 (+0.17), ROST: 62.73 (+0.35)
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:00AM CDT
This approval makes Edwards (EW) the first ever company in the U.S., which has had its THVs approved for TAVR therapy in intermediate risk patients.
MDT: 87.32 (+0.34), ANIP: 59.86 (-1.56), EW: 115.85 (-0.02), ANIK: 47.89 (-0.05)
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:12PM CDT
Edwards' (EW) Intuity Elite valve system is used to treat patients suffering from coronary artery disease and are required to undergo aortic valve replacement surgery.
HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), EW: 115.85 (-0.02), ANIK: 47.89 (-0.05)
EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval
PR Newswire - Mon Aug 15, 7:30AM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced U.S. Food and Drug Administration approval of the advanced EDWARDS INTUITY Elite valve system, a rapid deployment device for surgical aortic valve replacement. Built on the trusted PERIMOUNT tissue valve platform and incorporating innovations from transcatheter heart valves, the EDWARDS INTUITY Elite valve system is designed to facilitate minimally invasive surgery and streamline complex aortic valve replacements, thereby offering a cutting-edge treatment option for patients with aortic valve disease. The device is now commercially available.
EW: 115.85 (-0.02)
Look for Shares of Edwards Lifesciences to Potentially Pullback after Yesterday's 1.17% Rise
Comtex SmarTrend(R) - Tue Aug 09, 2:27PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $112.28 to a high of $114.05. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $113.99 on volume of 408,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 115.85 (-0.02)
Global Transcatheter Mitral Valve Replacement Market 2016-2020 - Key Vendors are Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices & Neovasc - Research and Markets
BusinessWire - Wed Aug 03, 10:31AM CDT
Research and Markets has announced the addition of the "Global Transcatheter Mitral Valve Replacement Market 2016-2020" report to their offering.
EW: 115.85 (-0.02)
Berry Plastics Group, Inc. Appoints Scott B. Ullem to the Company's Board of Directors
BusinessWire - Tue Aug 02, 7:30AM CDT
Berry Plastics Group, Inc. (NYSE:BERY), a leading global manufacturer and marketer of innovative consumer packaging and engineered specialty materials, today announced the appointment of Scott B. Ullem to its Board of Directors.
BERY: 45.97 (+0.48), EW: 115.85 (-0.02)
Edwards Lifesciences (EW) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:40AM CDT
Edwards Lifesciences Corp. (EW) saw its shares rise almost 6% in the last trading session.
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02)
Upgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Thu Jul 28, 3:52AM CDT
Edwards Lifesciences (NYSE:EW) was upgraded from Neutral to Buy at BofA/Merrill today. The stock closed yesterday at $114.44 on volume of 5.1 million shares, above average daily volume of 1.9 million. There is potential upside of 51.1% for shares of Edwards Lifesciences based on a current price of $114.44 and an average consensus analyst price target of $172.89. The stock should find initial support at its 50-day moving average (MA) of $96.47 and further support at its 200-day MA of $81.36.
EW: 115.85 (-0.02)
Twitter and Akamai skid; Apple and Edwards climb
AP - Wed Jul 27, 3:35PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
RHI: 38.50 (+0.28), AKAM: 55.33 (+0.26), GRMN: 48.75 (-0.11), ADI: 63.15 (+0.09), EW: 115.85 (-0.02), LL: 15.91 (+0.31), TWTR: 19.75 (+0.20), AAPL: 108.05 (+0.32)
After Yesterday's Rally of 6.43% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jul 27, 12:04PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $114.01 to a high of $117.46. Yesterday, the shares gained 6.4%, which took the trading range above the 3-day high of $108.38 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 115.85 (-0.02)
Edwards Lifesciences (EW) Tops Q2 Earnings, '16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 11:39AM CDT
Edwards Lifesciences (EW) ended the second quarter on an encouraging note, with its financial numbers squarely beating the Zacks Consensus Estimate.
ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CYNO: 51.59 (-0.36), EW: 115.85 (-0.02)
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 1.53% Gain
Comtex SmarTrend(R) - Wed Jun 08, 2:02PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $100.86 to a high of $103.30. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $102.19 on volume of 568,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 115.85 (-0.02)
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02), ARAY: 5.42 (+0.12), SYK: 115.60 (+0.37)
Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 59.90 (+0.47), EW: 115.85 (-0.02), LMNX: 21.12 (+0.19), CRY: 16.23 (+0.39)
Look for Shares of Edwards Lifesciences to Potentially Rebound after Yesterday's 1.02% Sell Off
Comtex SmarTrend(R) - Tue May 31, 2:23PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $98.64 to a high of $100.66. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $98.97 on volume of 657,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EW: 115.85 (-0.02)
Masimo (MASI) Hits 52-Week High: What's Backing the Stock?
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 8:07AM CDT
Shares of Masimo Corp. (MASI) scaled a new 52-week high of $59.90 on Sep 2.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EW: 115.85 (-0.02), NUVA: 66.74 (+0.68)
Edwards Lifesciences To Present At The 11th Annual Wells Fargo Healthcare Conference
PR Newswire - Thu Sep 01, 9:10AM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the 11th Annual Wells Fargo Healthcare Conference at the Westin Boston Waterfront in Boston, Massachusetts on Thursday, September 8, 2016.
EW: 115.85 (-0.02), WFC: 50.75 (+0.20)
Medical Equipment Stocks Technical Reports -- St. Jude Medical, Wright Medical, Edwards Lifesciences, and Steris
PR Newswire - Tue Aug 23, 7:05AM CDT
This morning's stocks in focus on Stock-Callers.com belong in the Healthcare sector which rose 0.3% in midday trading on Monday, August 22, 2016. As per Forbes, the Health Care Select Sector SPDR ETF (XLV) climbed 0.2%, up 4.21% on an YTD basis. Let us now review the following Medical Appliances and Equipment equities and see how they fared at the close: St. Jude Medical Inc. (NYSE: STJ), Wright Medical Group N.V. (NASDAQ: WMGI), Edwards Lifesciences Corp. (NYSE: EW), and Steris PLC (NYSE: STE). Download the free research reports on these stocks today:
WMGI: 24.71 (+0.10), STE: 71.00 (+0.89), EW: 115.85 (-0.02), STJ: 78.65 (+0.51), WMGIZ: 1.35 (unch)
Edwards Lifesciences: Rallies on Strong THV Sales, View Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 5:05PM CDT
Geographically Edwards Lifesciences (EW) excelled in both the U.S. as well as overseas, particularly in its transcatheter heart valve (THV) product segment.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EW: 115.85 (-0.02), IDXX: 114.09 (+0.93)
Stock Market News for August 19, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:10AM CDT
Benchmarks ended slightly higher on Thursday, boosted by gains in energy shares
EW: 115.85 (-0.02), DE: 84.47 (+0.42), WMT: 72.56 (+0.06), XOM: 87.60 (+0.18), TMUS: 47.29 (+1.04), GPS: 23.92 (-0.63), CVX: 101.10 (+0.17), ROST: 62.73 (+0.35)
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:00AM CDT
This approval makes Edwards (EW) the first ever company in the U.S., which has had its THVs approved for TAVR therapy in intermediate risk patients.
MDT: 87.32 (+0.34), ANIP: 59.86 (-1.56), EW: 115.85 (-0.02), ANIK: 47.89 (-0.05)
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:12PM CDT
Edwards' (EW) Intuity Elite valve system is used to treat patients suffering from coronary artery disease and are required to undergo aortic valve replacement surgery.
HSKA: 52.49 (-0.27), ANIP: 59.86 (-1.56), EW: 115.85 (-0.02), ANIK: 47.89 (-0.05)
EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval
PR Newswire - Mon Aug 15, 7:30AM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced U.S. Food and Drug Administration approval of the advanced EDWARDS INTUITY Elite valve system, a rapid deployment device for surgical aortic valve replacement. Built on the trusted PERIMOUNT tissue valve platform and incorporating innovations from transcatheter heart valves, the EDWARDS INTUITY Elite valve system is designed to facilitate minimally invasive surgery and streamline complex aortic valve replacements, thereby offering a cutting-edge treatment option for patients with aortic valve disease. The device is now commercially available.
EW: 115.85 (-0.02)
Look for Shares of Edwards Lifesciences to Potentially Pullback after Yesterday's 1.17% Rise
Comtex SmarTrend(R) - Tue Aug 09, 2:27PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $112.28 to a high of $114.05. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $113.99 on volume of 408,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 115.85 (-0.02)
Global Transcatheter Mitral Valve Replacement Market 2016-2020 - Key Vendors are Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices & Neovasc - Research and Markets
BusinessWire - Wed Aug 03, 10:31AM CDT
Research and Markets has announced the addition of the "Global Transcatheter Mitral Valve Replacement Market 2016-2020" report to their offering.
EW: 115.85 (-0.02)
Berry Plastics Group, Inc. Appoints Scott B. Ullem to the Company's Board of Directors
BusinessWire - Tue Aug 02, 7:30AM CDT
Berry Plastics Group, Inc. (NYSE:BERY), a leading global manufacturer and marketer of innovative consumer packaging and engineered specialty materials, today announced the appointment of Scott B. Ullem to its Board of Directors.
BERY: 45.97 (+0.48), EW: 115.85 (-0.02)
Edwards Lifesciences (EW) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:40AM CDT
Edwards Lifesciences Corp. (EW) saw its shares rise almost 6% in the last trading session.
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02)
Upgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Thu Jul 28, 3:52AM CDT
Edwards Lifesciences (NYSE:EW) was upgraded from Neutral to Buy at BofA/Merrill today. The stock closed yesterday at $114.44 on volume of 5.1 million shares, above average daily volume of 1.9 million. There is potential upside of 51.1% for shares of Edwards Lifesciences based on a current price of $114.44 and an average consensus analyst price target of $172.89. The stock should find initial support at its 50-day moving average (MA) of $96.47 and further support at its 200-day MA of $81.36.
EW: 115.85 (-0.02)
Twitter and Akamai skid; Apple and Edwards climb
AP - Wed Jul 27, 3:35PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
RHI: 38.50 (+0.28), AKAM: 55.33 (+0.26), GRMN: 48.75 (-0.11), ADI: 63.15 (+0.09), EW: 115.85 (-0.02), LL: 15.91 (+0.31), TWTR: 19.75 (+0.20), AAPL: 108.05 (+0.32)
After Yesterday's Rally of 6.43% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jul 27, 12:04PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $114.01 to a high of $117.46. Yesterday, the shares gained 6.4%, which took the trading range above the 3-day high of $108.38 on volume of 3.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 115.85 (-0.02)
Edwards Lifesciences (EW) Tops Q2 Earnings, '16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 11:39AM CDT
Edwards Lifesciences (EW) ended the second quarter on an encouraging note, with its financial numbers squarely beating the Zacks Consensus Estimate.
ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CYNO: 51.59 (-0.36), EW: 115.85 (-0.02)
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 1.53% Gain
Comtex SmarTrend(R) - Wed Jun 08, 2:02PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $100.86 to a high of $103.30. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $102.19 on volume of 568,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 115.85 (-0.02)
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02), ARAY: 5.42 (+0.12), SYK: 115.60 (+0.37)
Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 59.90 (+0.47), EW: 115.85 (-0.02), LMNX: 21.12 (+0.19), CRY: 16.23 (+0.39)
Look for Shares of Edwards Lifesciences to Potentially Rebound after Yesterday's 1.02% Sell Off
Comtex SmarTrend(R) - Tue May 31, 2:23PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $98.64 to a high of $100.66. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $98.97 on volume of 657,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EW: 115.85 (-0.02)
(0)
(0)Scroll down for more posts ▼